--- title: "The Caremark Deal: Will PBM Reforms Lower Prescription Bills?" description: The Caremark deal could reshape drug prices, insulin costs, pharmacy payments, and hidden PBM rules affecting household prescription bills nationwide. image: https://americanimpact.org/hubfs/image-Aug-02-2026-09-20-57-5776-PM.jpg --- [![American Impact - Trimmed Logo one PNG](https://americanimpact.org/hs-fs/hubfs/American%20Impact%20-%20Trimmed%20Logo%20one%20PNG.png?width=1249&height=574&name=American%20Impact%20-%20Trimmed%20Logo%20one%20PNG.png "American Impact - Trimmed Logo one PNG")](https://americanimpact.org/) - [Home](https://americanimpact.org) - [About](https://americanimpact.org/about-american-impact) - [About the Foundation](https://americanimpact.org/about-the-american-impact-0) - [FAQs](https://americanimpact.org/frequently-asked-questions) - Issues - [Legislation](https://americanimpact.org/legislation) - [Monetary Policy](https://americanimpact.org/monetary-policy) - [Investing](https://americanimpact.org/investing) - [Entitlement Programs](https://americanimpact.org/entitlement-programs) - [Government Taxation, Spending, and Debt](https://americanimpact.org/government-taxation-spending-and-debt) - [Financial Literacy in the United States](https://americanimpact.org/financial-literacy) - [Articles](https://americanimpact.org/blog) - [Donate](https://americanimpact.org/donate) - [Charitable Solicitation Registration Statement](https://americanimpact.org/charitable-solicitation-registration-statement) [Contact Us](https://americanimpact.org/contact) # The Caremark Deal: Will PBM Reforms Lower Prescription Bills? [American Impact](https://americanimpact.org/blog/author/american-impact) Aug 6, 2026, 10:16:55 AM ###### [Financial Literacy](https://americanimpact.org/blog/tag/financial-literacy) *Hidden prescription middlemen promise savings, yet their pricing rules can leave patients paying more at pharmacy counters.* ## **What to Know** - The proposed Caremark settlement would lock in **$8.5 billion** in pricing and reimbursement reforms over **10 years**, with up to **$4.5 billion** more possible through point-of-sale rebates. - Eligible members could receive insulin cost protection of **$25 per month**, depending on sponsor participation and qualifying coverage. - The agreement targets **3** pricing practices by limiting rebate guarantees, spread pricing, and fees tied to drug list prices. - The deal affects **1** major PBM, so broader savings will depend on enforcement, employer choices, competitor responses, and wider reform. - Eligible TrumpRx purchases may count toward deductibles only after required legal changes take effect. Prescription prices are shaped before patients reach the pharmacy counter. Pharmacy benefit managers, or PBMs, negotiate with manufacturers, build formularies, and determine pharmacy payments. Those duties can lower costs but also give PBMs influence over access and household spending. [The Caremark agreement](https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin) targets that hidden layer, not only the manufacturer’s price. It seeks to weaken high-list-price incentives, improve transparency, and provide fairer pharmacy reimbursement. The test is whether those changes become visible savings for families. ## **How PBMs Became Hidden Toll Collectors** PBM contracts can include rebates, fees, and spread pricing. PBMs often favor expensive drugs with large manufacturer rebates over cheaper alternatives. Patients may then pay costs based on the higher list price, leaving them with higher out-of-pocket expenses at checkout. The[Federal Trade Commission](https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin) alleged that Caremark and other PBMs used rebates that artificially inflated insulin list prices. Community pharmacies also complained that reimbursement could fall below acquisition costs, forcing them to absorb losses or stop dispensing drugs. Those pressures explain why the settlement addresses all three groups together. Rebates can reduce premiums or plan spending without helping a patient at checkout. Removing them without replacing their value could shift costs elsewhere. That tradeoff makes the settlement terms more important than the reform promise. ## **Caremark’s Proposed Pricing Reforms** The[Federal Trade Commission](https://www.ftc.gov/legal-library/browse/cases-proceedings/221-0114-caremark-rx-zinc-health-services-et-al-matter-insulin) announced the agreement on **July 14, 2026** after a case launched in **2024**. The proposed order locks in up to **$8.5 billion** across **10 years** and could unlock another **$4.5 billion** through point-of-sale rebates. The commission accepted it by a **1-0-1** vote and opened a **30-day** comment period. ![](https://americanimpact.org/hs-fs/hubfs/undefined-Aug-06-2026-03-16-26-4024-PM.png?width=560&height=418&name=undefined-Aug-06-2026-03-16-26-4024-PM.png) Caremark Settlement Targets Billions In Hidden Drug Costs. Created via Gemini. Caremark would offer counter rebates, a path away from rebate guarantees and spread pricing, and fees separated from drug list prices. Community pharmacies could choose reimbursement based on acquisition cost plus a fee. These changes seek to align payment with actual costs instead of hidden arrangements. TrumpRx purchases would not count toward every deductible immediately. The requirement depends on specified legal changes, eligible drugs, and sponsor participation. Those conditions shift attention from what the agreement promises to what patients experience. ## **Potential Savings at the Pharmacy Counter** [Reuters](https://www.reuters.com/world/cvs-settles-with-ftc-agrees-count-trumprx-drug-purchases-towards-insurance-2026-07-14/) reported that Caremark would cap eligible members’ insulin costs at **$25 per month**. The proposed order also requires affordability programs when a sponsor adopts a qualifying insulin formulary, unless it opts out in writing. Counting eligible purchases toward annual limits could make discounted prices more useful. ![](https://americanimpact.org/hs-fs/hubfs/undefined-Aug-06-2026-03-16-25-2806-PM.png?width=593&height=443&name=undefined-Aug-06-2026-03-16-25-2806-PM.png) Insulin Protection Could Cap Monthly Patient Costs At Twenty-Five Dollars. Created via Gemini. Savings will vary because employers and other sponsors choose benefit designs. A standard option does not guarantee adoption, and a lower counter price may be balanced against premiums or other expenses. Consumers need clear explanations showing how discounts, deductibles, and maximums interact. Patients will judge the deal by receipts, while independent stores will judge whether reimbursement covers inventory and operations. Those outcomes matter more than projections. They also raise whether one agreement can change the wider market. ## **Limits on Patient Relief** The proposed consent order is not yet final. Because it targets only Caremark, relief depends on whether employers adopt the new options and whether competitors follow suit. Enforcement, monitoring, and future regulations will determine how much benefit reaches patients. Without broader reform, PBMs could restructure contracts while preserving costs through other channels. A durable reset requires transparent net prices, understandable benefits, reliable pharmacy reimbursement, and oversight that compares counter savings with premiums and total plan spending. ## **Wrap Up** The proposed Caremark agreement would challenge rebate incentives, spread pricing, and reimbursement practices that can obscure prescription costs. Eligible patients could benefit from lower insulin costs, point-of-sale rebates, and deductible credit for qualifying TrumpRx purchases, although some provisions depend on sponsor adoption and legal changes. Patients should watch whether those protections produce lower pharmacy receipts without increasing premiums or reducing access elsewhere. The deal’s success will depend on enforcement, clear benefit information, stable pharmacy reimbursement, and whether similar reforms extend beyond Caremark.   [American Impact](https://americanimpact.org/blog/author/american-impact) Share this article on [mailto:?subject=Check%20out%20The%20Caremark%20Deal:%20Will%20PBM%20Reforms%20Lower%20Prescription%20Bills?%20&body=Check%20out%20https://americanimpact.org/blog/the-prescription-drug-middleman-reset-and-whether-the-caremark-deal-will-lower-pharmacy-bills](mailto:?subject=Check%20out%20The%20Caremark%20Deal:%20Will%20PBM%20Reforms%20Lower%20Prescription%20Bills?%20&body=Check%20out%20https://americanimpact.org/blog/the-prescription-drug-middleman-reset-and-whether-the-caremark-deal-will-lower-pharmacy-bills) ##### Read more - [The Price on the Sign: Why Gasoline Remains an Immediate Affordability Test](https://americanimpact.org/blog/the-price-on-the-sign-why-gasoline-remains-an-immediate-affordability-test) - [No Roadblocks, No Special Favors: A State Framework for Data-Center Growth](https://americanimpact.org/blog/no-roadblocks-no-special-favors-a-state-framework-for-data-center-growth) - [The AI Utility Surcharge and Why Households May Pay for Grid Expansion](https://americanimpact.org/blog/the-ai-utility-surcharge-and-why-households-may-pay-for-grid-expansion) ![American Impact - Trimmed Logo white](https://americanimpact.org/hubfs/American%20Impact%20-%20Trimmed%20Logo%20white.png "American Impact - Trimmed Logo white") **Our Contact Info:** American Impact, Inc. 3232 McKinney Ave Ste 500 Dallas, TX 75204 **Phone:** (214) 429-3710 **General Email:** **[info@americanimpact.org](mailto:info@americanimpact.org)** *American Impact and American Impact Foundation are affiliate nonprofit organizations with missions to provide civic and voter engagement and provide financial literacy and fiscal public policy education at the federal, state and local level.* *Contributions to American Impact, an IRS designated 501(c)(4) nonprofit, are not tax deductible.  American Impact Foundation is a section 501(c)(3) non-profit organization under the IRS and contributions are tax deductible to the extent provided by law.* --- © 2024 American Impact Foundation | [Privacy](https://20089053.hs-sites.com/privacy) and [Donation Refund Policy ](https://20089053.hs-sites.com/refundpolicy) [Legal](https://americanimpact.org/charitable-solicitation-registration-statement) [Privacy Policy](https://americanimpact.org/privacy)